HAYWARD, Calif., Feb. 3, 2025 /PRNewswire/ — Avirmax Biopharma, Inc., a leader in the development of the next generation of AAV gene therapies, today announced completion of the first cohort of the ...
HAYWARD, Calif., Nov. 21, 2024 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first patient has been successfully dosed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results